← Back to Search

Social Marketing Campaign for HPV Vaccine Hesitancy

N/A
Recruiting
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in health science students' self-reported vhs score pre-post intervention (6 week period / phase 1)
Awards & highlights

Study Summary

This trial is aiming to increase HPV vaccination rates in Southwest VA by developing and executing a media/social marketing intervention. Nursing/Dental Asst students will create PSAs, and a regional transportation system will be used to spread awareness. Qualitative/quantitative data will be used to assess the impact of the intervention.

Who is the study for?
This trial is for adults over 18 who are health sciences students at a regional community college, or those who use a non-profit's rideshare buses and social media. It also includes employees of the college or non-profit involved in the study. The focus is on reducing HPV vaccine hesitancy.Check my eligibility
What is being tested?
The trial tests an intervention called Appalachian Voices for Health, which uses student-created PSAs to promote HPV vaccination through social marketing campaigns on buses and online. Its impact on vaccine hesitancy and perceptions will be evaluated using surveys and focus groups.See study design
What are the potential side effects?
Since this trial focuses on a social marketing campaign rather than a medical treatment, there are no direct side effects related to medications or vaccines being tested.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in health science students' self-reported vhs score pre-post intervention (6 week period / phase 1)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in health science students' self-reported vhs score pre-post intervention (6 week period / phase 1) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Vaccination hesitancy scale modified for the HPV vaccine (VHS-HPV)
Secondary outcome measures
Vaccination hesitancy scale (VHS)

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Social Marketing Campaign (Phase 2)Experimental Treatment1 Intervention
Group II: PSA Development (Phase 1)Experimental Treatment1 Intervention
Group III: Organizational StakeholdersActive Control1 Intervention
Organizational stakeholders from organizations involved in Phase 1 and 2 will take part in a focus group after their respective phases have been completed to learn more about their experience.

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
753 Previous Clinical Trials
1,244,811 Total Patients Enrolled

Media Library

PSA Development (Phase 1) Clinical Trial Eligibility Overview. Trial Name: NCT05860725 — N/A
Human Papillomavirus Research Study Groups: PSA Development (Phase 1), Social Marketing Campaign (Phase 2), Organizational Stakeholders
Human Papillomavirus Clinical Trial 2023: PSA Development (Phase 1) Highlights & Side Effects. Trial Name: NCT05860725 — N/A
PSA Development (Phase 1) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05860725 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies remaining in this experiment for individuals?

"Affirmative. Clinicaltrials.gov hosts information which confirms that this medical trial, initially published on March 13th 2023, is actively seeking participants. The research project has a goal of enrolling 220 individuals at 1 different healthcare centre."

Answered by AI

How many individuals are being recruited for this clinical experiment?

"Affirmative. According to the clinicaltrials.gov listing, this research is currently recruiting participants with a posting date of March 13th 2023 and an edit on May 5th 2023. To complete trial objectives 220 patients need to be enrolled at 1 medical site."

Answered by AI
~106 spots leftby Apr 2025